Harvard John A. Paulson School of Engineering and Applied Sciences: Confronting COVID-19

Six months into the global pandemic, there is still no specific antiviral treatment for COVID-19. A team of Harvard undergraduates is working to change that.

Members of Harvard’s International Genetically Engineered Machine (iGEM) team are using computational biology to develop a therapy that enables the body to quickly develop COVID-19 antibodies and jumpstart the immune system’s battle against the disease.

View full article in Harvard John A. Paulson School of Engineering and Applied Sciences.

Interested in Becoming a Community Partner?

The Fourth Industrial Revolution may be one of the most important conversations of our time.

Help bring next-generation technologies to the US by becoming a Greater Boston Community partner.